Insider · CIK 0001008227

QUAY STEVEN C

Reports to the SEC for 2 companies · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001008227

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-27	ATOSATOSSA THERAPEUTICS, INC.A Award	Director, President & CEO	AAward	+65K sh	—	—	88,038
2026-01-20	ATOSATOSSA THERAPEUTICS, INC.A Award	Director, President & CEO	AAward	+325K sh	—	—	339,101
2026-01-20	ATOSATOSSA THERAPEUTICS, INC. · Stock Options (right to buy)A Award	Director, President & CEO	AAward	+950K sh	$0.60	+$573K	950,000
2026-01-20	ATOSATOSSA THERAPEUTICS, INC.A Award	Director, President & CEO	AAward	+332K sh	—	—	345,572
2026-01-20	ATOSATOSSA THERAPEUTICS, INC. · Stock Options (right to buy)A Award	Director, President & CEO	AAward	+950K sh	$0.60	+$573K	950,000
2025-05-21	ATOSATOSSA THERAPEUTICS, INC.P Purchase	Director, President & CEO	PPurchase	+11.2K sh	$0.88	+$9,886.948	13,898
2025-05-15	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+1.37M sh	—	—	1,366,062
2024-06-27	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+1.8M sh	—	—	1,795,100
2023-03-02	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+1.87M sh	—	—	1,873,100
2022-02-24	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+1.9M sh	—	—	1,900,000
2021-05-14	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+1.9M sh	—	—	1,900,000
2021-05-14	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+1.9M sh	—	—	1,900,000
2020-04-09	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+195K sh	—	—	195,000
2020-04-09	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+1.31M sh	—	—	1,305,000
2019-01-13	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−2.3M sh	—	—	0
2019-01-13	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+2.3M sh	—	—	2,300,000
2018-06-27	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+2.3M sh	—	—	2,300,000
2018-05-30	ATOSATOSSA THERAPEUTICS, INC. · Series B Convertible Preferred StockP Purchase	Director, President & CEO	PPurchase	+8 sh	$1000.00	+$8,000	8
2018-05-30	ATOSATOSSA THERAPEUTICS, INC. · WarrantsP Purchase	Director, President & CEO	PPurchase	+2,272 sh	$1000.00	+$2.27M	2,272
2017-05-24	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+576K sh	—	—	651,785
2016-05-18	ATOSATOSSA THERAPEUTICS, INC. · Common Stock (right to buy)A Award	Director, President & CEO	AAward	+569K sh	—	—	569,194
2016-03-09	ATOSATOSSA THERAPEUTICS, INC.P Purchase	Director, President & CEO	PPurchase	+15K sh	$0.37	+$5,550	4,826,858
2016-02-16	ATOSATOSSA THERAPEUTICS, INC.P Purchase	Director, President & CEO	PPurchase	+15K sh	$0.53	+$7,950	4,811,858
2016-01-19	ATOSATOSSA THERAPEUTICS, INC.P Purchase	Director, President & CEO	PPurchase	+50K sh	$0.20	+$10K	4,796,858
2015-03-16	ATOSATOSSA THERAPEUTICS, INC. · Stock OptionsA Award	Director, President & CEO	AAward	+275K sh	—	—	275,000
2013-10-01	ATOSATOSSA THERAPEUTICS, INC.S Sale	Director, President & CEO	SSale	−7,265 sh	$5.66	−$41.1K	4,268,315
2013-07-18	ATOSATOSSA THERAPEUTICS, INC.G Gift	Director, President & CEO	GGift	−100K sh	—	—	483,543
2013-07-18	ATOSATOSSA THERAPEUTICS, INC.G Gift	Director, President & CEO	GGift	−5,000 sh	—	—	478,543
2013-05-28	ATOSATOSSA THERAPEUTICS, INC.G Gift	Director, President & CEO	GGift	−1,000 sh	—	—	583,543
2013-03-11	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+44.2K sh	—	—	44,194
2009-03-20	ATRXAdhera Therapeutics, Inc.A Award	Director	AAward	+731K sh	—	—	1,166,504
2009-03-16	ATRXAdhera Therapeutics, Inc. · Common Stock Options of MDRNA, Inc.J Other	Director	JOther	−800K sh	$12.94	−$10.4M	1,704,247
2008-10-28	ATRXAdhera Therapeutics, Inc. · Common Stock Options of MDRNA, Inc.J Other	Director	JOther	−600K sh	$14.72	−$8.83M	2,604,247
2008-10-28	ATRXAdhera Therapeutics, Inc. · Common Stock Options of MDRNA, Inc.J Other	Director	JOther	−100K sh	$25.00	−$2.5M	2,504,247
2007-06-07	ATRXAdhera Therapeutics, Inc.S Sale	Director	SSale	−2,000 sh	$11.31	−$22.6K	457,462
2007-06-07	ATRXAdhera Therapeutics, Inc.S Sale	Director	SSale	−2,000 sh	$11.01	−$22K	455,462
2007-06-07	ATRXAdhera Therapeutics, Inc.S Sale	Director	SSale	−2,000 sh	$10.93	−$21.9K	453,462
2007-06-07	ATRXAdhera Therapeutics, Inc.S Sale	Director	SSale	−400 sh	$10.95	−$4,380	453,062
2006-06-15	ATRXAdhera Therapeutics, Inc.S Sale	Director	SSale	−2,000 sh	$14.34	−$28.7K	505,950
2006-06-15	ATRXAdhera Therapeutics, Inc.S Sale	Director	SSale	−2,000 sh	$14.67	−$29.3K	503,950
2006-06-15	ATRXAdhera Therapeutics, Inc.S Sale	Director	SSale	−1,540 sh	$14.73	−$22.7K	502,410
2006-03-16	ATRXAdhera Therapeutics, Inc.S Sale	Director	SSale	−400 sh	$15.87	−$6,348	517,600
2006-03-16	ATRXAdhera Therapeutics, Inc.S Sale	Director	SSale	−1,550 sh	$16.25	−$25.2K	516,050
2006-03-16	ATRXAdhera Therapeutics, Inc.S Sale	Director	SSale	−1,000 sh	$16.26	−$16.3K	515,050
2006-03-16	ATRXAdhera Therapeutics, Inc.S Sale	Director	SSale	−2,000 sh	$16.30	−$32.6K	513,050
2006-02-01	ATRXAdhera Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−852 sh	—	—	165
2006-02-01	ATRXAdhera Therapeutics, Inc. · Nastech Pharmaceutical Company Inc Stock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−1,333 sh	$9.78	−$13K	2,667
2005-07-20	ATRXAdhera Therapeutics, Inc.A Award	Director	AAward	+168K sh	—	—	436,000
2005-07-20	ATRXAdhera Therapeutics, Inc. · Nastech Pharmaceutical Company Inc Stock OptionsA Award	Director	AAward	+600K sh	$14.72	+$8.83M	1,545,846
2005-07-11	ATRXAdhera Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+54.2K sh	$15.00	+$812K	322,154

Recent filings

Accepted (ET)
Mar 314
QUAY STEVEN C0001193125-26-134861
SEC(opens sec.gov)
Jan 304/A
QUAY STEVEN C0001193125-26-030571
SEC(opens sec.gov)
Jan 224
QUAY STEVEN C0001193125-26-019273
SEC(opens sec.gov)
May 224
QUAY STEVEN C0000950170-25-076523
SEC(opens sec.gov)
May 164
QUAY STEVEN C0000950170-25-073520
SEC(opens sec.gov)
Jul 14
QUAY STEVEN C0000950170-24-079559
SEC(opens sec.gov)
Mar 64
QUAY STEVEN C0001437749-23-005533
SEC(opens sec.gov)
Feb 284
QUAY STEVEN C0001437749-22-004667
SEC(opens sec.gov)
May 184
QUAY STEVEN C0001437749-21-012674
SEC(opens sec.gov)
May 184
QUAY STEVEN C0001437749-21-012676
SEC(opens sec.gov)
Apr 134
QUAY STEVEN C0001437749-20-007628
SEC(opens sec.gov)
Jan 154
QUAY STEVEN C0001615774-19-000645
SEC(opens sec.gov)
Jun 294
QUAY STEVEN C0001615774-18-005997
SEC(opens sec.gov)
May 314
QUAY STEVEN C0001615774-18-004657
SEC(opens sec.gov)
May 264
ATOSSA GENETICS INC0001615774-17-002743
SEC(opens sec.gov)

Companies

Address

C/O ATOSSA THERAPEUTICS, INC., 1448 NW MARKET STREET, SUITE 500

SEATTLE, WA, 98107